Skip to main content
. 2024 Mar 12;42(15):1766–1775. doi: 10.1200/JCO.23.02474

FIG 1.

FIG 1.

Screening, registration, random assignment, and reasons for discontinuing study treatment. GVHD, graft-versus-host disease; HCT, hematopoietic cell transplantation.